IL-1-induced ERK1/2 activation up-regulates p21Waf1/Cip1 protein by inhibition of degradation via ubiquitin-independent pathway in human melanoma cells A375
- 1. Department of Molecular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603 (Japan)
- 2. Department of Drug Metabolism and Disposition, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603 (Japan)
Description
IL-1 inhibits the proliferation of human melanoma cells A375 by arresting the cell cycle at G0/G1 phase, which accompanies the increase of p21Waf1/Cip1 (p21) protein. Here, we demonstrate that IL-1 induces the stabilization of p21 protein via ERK1/2 pathway. The degradation of p21 was inhibited by IL-1, however the ubiquitination level of p21 was not affected. In addition, the degradation of non-ubiquitinated form of lysine less mutant p21-K6R was also inhibited by IL-1, suggesting that IL-1 stabilized p21 protein via ubiquitin-independent pathway. Furthermore, the inhibition of p21 protein degradation was prevented by a selective inhibitor of ERK1/2 pathway, PD98059. These results suggest that IL-1-induced ERK1/2 activation leads to the up-regulation of p21 by inhibiting degradation via ubiquitin-independent pathway in human melanoma cells A375.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.bbrc.2010.01.027Additional details
Identifiers
- DOI
- 10.1016/j.bbrc.2010.01.027;
- PII
- S0006-291X(10)00057-4;
Publishing Information
- Journal Title
- Biochemical and Biophysical Research Communications
- Journal Volume
- 392
- Journal Issue
- 3
- Journal Page Range
- p. 369-372
- ISSN
- 0006-291X
- CODEN
- BBRCA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 45023282
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- CELL CYCLE; CELL PROLIFERATION; INHIBITION; LYSINE; MELANOMAS; MUTANTS; PROTEINS
- Descriptors DEC
- AMINO ACIDS; CARBOXYLIC ACIDS; CARCINOMAS; DISEASES; EPITHELIOMAS; NEOPLASMS; ORGANIC ACIDS; ORGANIC COMPOUNDS
Optional Information
- Copyright
- Copyright (c) 2010 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.